Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoKeytruda, 74.8%, survived for 2.5 years without their cancer recurring. That compares to 55.6% for ...
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 2 days agoLast year, Keytruda generated $25bn in sales while Opdivo accumulated $9bn in revenue. Meanwhile,...
Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
Zacks via Yahoo Finance· 2 days agoSummit Therapeutics (SMMT) surges after data from a late-stage study shows that its experimental...
3 Reasons to Buy Moderna Stock
The Motley Fool via AOL· 6 days agoIt will take...products. It used the windfall it experienced during the earlier pandemic years to make substantial progress. Let's consider two of the...
Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 1 day agoWe recently published a list entitled Billionaire Israel Englander’s Top 10 Stock Picks for 2024....
Biotech Insiders Share Five Lessons From Pioneering New Medicines
Forbes· 4 days agoWhy does this matter for patients? Enter the cutting-edge biotech and pharma companies who embark on the grueling, risky, and time-consuming path to developing a first-in-class drug ...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 4 days agoMore to come Primarily because...has no approved vaccines. With Merck, Moderna is testing a combination of Merck's Keytruda with Moderna's experimental ...
The Hunt for Virus Treatments Continues Post Covid-19
Digital Journal· 7 days ago(NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. The threat of viruses is back in the ...
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
